🔎 Trials Near Me

Home › Acute Myeloid Leukemia › New York › Greenburgh

Acute Myeloid Leukemia clinical trials in Greenburgh, NY

18 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Greenburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

RecruitingPhase 1
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Ages 18 to 59 · All sexes · Updated Sep 28, 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

RecruitingPhase 1
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Ages 18 to 59 · All sexes · Updated Sep 22, 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecruitingPhase 3
  • New York Medical College, Valhalla · 5 mi away
6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

RecruitingPhase 1
  • New York Medical College /ID# 275597, Valhalla · 5 mi away
6 Months – 17 Years · All sexes · Updated Sep 9, 2026 · NCT07306832

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

RecruitingPhase 2
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
Ages 60 and older · All sexes · Updated Jul 17, 2026 · NCT07392242

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

RecruitingPhase 1
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT05756777

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

RecruitingPhase 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
Ages 1 and older · All sexes · Updated Jun 22, 2026 · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

RecruitingPhase 1/2
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
Ages 12 and older · All sexes · Updated Jun 22, 2026 · NCT07356154

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

RecruitingPhase 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
Ages 18 to 70 · All sexes · Updated Jun 17, 2026 · NCT07011004

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

RecruitingPhase 1
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

RecruitingPhase 2
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi away
Ages 18 and older · All sexes · Updated Feb 24, 2026 · NCT06773208

Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

RecruitingPhase 2
  • White Plains Hospital, White Plains · 4 mi away
Ages 18 and older · All sexes · Updated Jan 5, 2026 · NCT05184842

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Greenburgh

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.